期刊文献+

融合基因TMPRSS2:ERG与前列腺癌病理分级关系的研究 被引量:2

Relationship between TMPRSS2:ERG and the pathological grade of prostate cancer
下载PDF
导出
摘要 目的:研究融合基因TMPRSS2:ERG和前列腺癌病理分级的关系。方法:选取前列腺癌的穿刺标本62例为病例组,同时选择10例良性前列腺增生(BPH)患者为对照组,同时纳入9株前列腺癌细胞株作为对照,采用巢式RT-PCR检测融合基因TMPRSS2:ERG,比较融合基因阳性和阴性患者Gleason评分的差异,Logistic回归法分析TMPRSS2:ERG和前列腺癌病理特征的关系。结果:62例前列腺癌患者中有28例检测出TMPRSS2:ERG融合基因,阳性率为45.16%;10例BPH和9株癌细胞株中均未检测出该融合基因。融合基因TMPRSS2:ERG阳性和阴性患者Gleason评分无显著差异(Z=-0.609,P=0.542),但融合基因阳性患者Gleason主评分显著高于阴性患者(Z=-2.600,P=0.009)。单因素Logistic回归分析显示,筛状结构、泡沫状腺体和印戒癌细胞分别与融合基因TMPRSS2:ERG有关联(OR=6.25,P=0.002;OR=6.666,P=0.023;OR=3.24,P=0.035);多因素Logistic回归分析显示,该融合基因和筛状结构有关(OR=3.750,P=0.033)。结论:TMPRSS2:ERG融合基因和前列腺癌中到高级的病理分级有关。 Objective:To study the relationship between TMPRSS2:ERG gene fusion and the pathological grade of prostate cancer(PCa).Methods:We collected fresh prostatic tissue samples from 62 patients with PCa and another 10 with benign prostatic hyperplasia(BPH)and included 9 cancer cell strains as the control.We examined the TMPRSS2:ERG fusion gene in the PCa samples by nest RT-PCR,compared the Gleason scores between the TMPRSS2:ERG-positive and-negative cases,and analyzed the association of TMPRSS2:ERG fusion with the pathological features of PCa.Results:The TMPRSS2:ERG fusion gene was detected in 28(45.16%)of the PCa cases,but in none of the 10 BPH cases or the 9 cancer cell strains.No statistically significant differences were found in the Gleason scores between the TMPRSS2:ERG-positive and-negative cases(Z =-0.609,P = 0.542),but the primary Gleason score was markedly higher in the former than in the latter(Z =-2.600,P = 0.009).Univariate logistic regression analysis showed that TMPRSS2:ERG was associated with the cribriform growth pattern(OR = 6.250,P = 0.002),foamy gland morphology(OR = 6.666,P = 0.023),and signet-ring cells(OR = 3.240,P = 0.035),but multivariate logistic regression analysis manifested that it was associated with the cribriform growth pattern only(OR = 3.750,P = 0.033).Conclusion:TMPRSS2:ERG gene fusion was associated with higher pathological grades of prostate cancer.
出处 《中华男科学杂志》 CAS CSCD 北大核心 2015年第10期887-891,共5页 National Journal of Andrology
关键词 前列腺癌 TMPRSS2:ERG融合基因 病理分级 GLEASON评分 病理特征 prostate cancer TMPRSS2: ERG pathological grade Gleason score pathological feature
  • 相关文献

参考文献19

  • 1Tomlins SA,Rhodes DR,Perner S,et al.Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.Science,2005,310(5748):644-648.
  • 2Mehra R,Tomlins SA,Shen R,et al.Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer.Mod Pathol,2007,20(5):538-544.
  • 3Fernández-Serra A,Rubio L,Calatrava A,et al.Molecular characterization and clinical impact of TMPRSS2-ERG rearrangement on prostate cancer:Comparison between FISH and RT-PCR.Biomed Res Int,2013,2013:465179.
  • 4Rajput AB,Miller MA,De Luca A,et al.Frequency of the TMPRSS2:ERG gene fusion is increased in moderate to poorly differentiated prostate cancers.J Clin Pathol,2007,60(11):1238-1243.
  • 5Lin DW,Newcomb LF,Brown EC,et al.Urinary TMPRSS2:ERG and PCA3 in an active surveillance cohort:Results from a baseline analysis in the Canary Prostate Active Surveillance Study.Clin Cancer Res,2013,19(9):2442-2450.
  • 6Perner S,Demichelis F,Beroukhim R,et al.TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer.Cancer Res,2006,66(17):8337-8341.
  • 7Wang J,Cai Y,Ren C,et al.Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer.Cancer Res,2006,66(17):8347-8351.
  • 8Han B,Mehra R,Suleman K,et al.Characterization of ETS gene aberrations in select histologic variants of prostate carcinoma.Mod Pathol,2009,22(9):1176-1185.
  • 9Pettersson A,Graff RE,Bauer SR,et al.The TMPRSS2:ERG rearrangement,ERG expression,and prostate cancer outcomes:A cohort study and meta-analysis.Cancer Epidemiol Biomarkers Prev,2012,21(9):1497-1509.
  • 10Nam RK,Sugar L,Yang W,et al.Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer.Br J Cancer,2007,97(12):1690-1695.

二级参考文献2

共引文献11

同被引文献6

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部